![](https://medfyle.com/articles/p-use-of-real-time-cgm-is-associated-with-fewer-hospitalizations-compared-with-smbg-in-the-insulin-treated-medicare-population/download_file?filename=articles%2F102_libraryimage.jpg)
Diabetes
| Glucose Monitoring and Sensing
Diabetes
Glucose Monitoring and Sensing
![](https://medfyle.com/files/organizations/ADA.jpg)
Use of Real-Time CGM Is Associated with Fewer Hospitalizations Compared with SMBG in the Insulin-Treated Medicare Population
book_2
Source:
ADA 2020 - Poster session
calendar_today
Published on Medfyle:
July 2020
headphones
4
min
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Key messages
- This study used data from The Centers for Medicare and Medicaid to assess the clinical impact of using real-time CGM (Dexcom G5) by comparing a cohort of Medicare beneficiaries who acquired a CGM device from July 2017 thru January 2018 (n=841) with a cohort of beneficiaries (n=224,484) who continued SMBG during the same period.
- SMBG was associated with 35% more hospitalizations than CGM (35.5% vs. 26.2%) and 52% more inpatient visits (0.70 vs. 0.46) over 6 months (both p <0.0001).
- Wider use of CGM among CMS beneficiaries with diabetes could significantly reduce these costs through reduced hospitalizations and inpatient visits
Presenting Author
Read more
arrow_downward
Hide
arrow_upward
David G. Marrero, PhD
Director, Center for Border Health Disparities
Professor of Public Health
University of Arizona Health Sciences
Tucson, Arizona, USA